
Striders Impex Ltd IPO Price Range is ₹71 - ₹72, with a minimum investment of ₹2,30,400 for 3200 shares per lot.
Subscription Rate
1.31x
as on 02 Mar 2026, 05:10PM IST
Minimum Investment
₹2,30,400
/ 3200 shares
IPO Status
Price Band
₹71 - ₹72
Bidding Dates
Feb 26, 2026 - Mar 2, 2026
Issue Size
₹36.29 Cr
Lot Size
1600 shares
Min Investment
₹2,30,400
Listing Exchange
NSE


as on 02 Mar 2026, 05:10PM IST
IPO subscribed over
🚀 1.31x
This IPO has been subscribed by 0.777x in the retail category and 2.035x in the QIB category.
| Total Subscription | 1.31x |
| Retail Individual Investors | 0.777x |
| Qualified Institutional Buyers | 2.035x |
| Non Institutional Investors | 1.518x |
The companys business operations and brand positioning are significantly dependent on the continued right to use certain licensedintellectual property including trademarks and marketing content obtained from third-party owners.
The companys ability to utilise certain intellectual property and related rights is subject to licensing agreements with third-partyowners, which are typically for fixed durations and subject to renewal and also exposed to termination
There have been instances of past discrepancies and non-compliances in filings with the Registrar of Companies underthe Companies Act, which may result in regulatory actions.
A significant portion of the companys revenue comes from key customers, and losing one or more of them, experiencing a declinein their financial health or business outlook, or facing a reduction in their demand for its products could negatively impactthe companys business, operating results, financial condition, and cash flows.
The Company is dependent on few suppliers for purchase of goods. Loss of any of these large suppliers may affect the companysbusiness operations adversely.
The Company may be subject to legal proceedings or litigation arising from its operations. Such matters could result infinancial liabilities, reputational harm, and diversion of managements attention, potentially impacting business performanceand stability.
The company rely on third-party manufacturers for product supply, and any disruption in these arrangements could adversely affectthe companys business and operations.
The Companys reliance on purchase order-based arrangements with China-based manufacturers exposes it topotential supply chain disruptions and financial risks
The companys revenues are dependent on non-exclusive license agreements and few agreements are due to expire between 2025 and2026, and renewal of these agreements is uncertain.
The Company is exposed to fluctuations in royalty costs and licensing fee structures. Changes in these expenses can affectcost management. Unfavourable variations may increase operational costs and impact financial performance.